Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cervical cancer screening in France.

P Schaffer1, H Sancho-Garnier, M Fender

  • 1Programme EVE, Strasbourg, France.

European Journal of Cancer (Oxford, England : 1990)
|November 10, 2000
PubMed
Summary

France is seeing fewer cervical cancer cases due to widespread screening. Efforts are ongoing to increase participation, especially among older women, and improve quality control for cervical smears.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of chalcopyrite-binding peptides for flotation applications using phage display and deep sequencing.

Journal of biotechnology·2026
Same author

Game-based training to improve the compliance of hospital pharmacy operators with handwashing guidelines.

The Journal of hospital infection·2023
Same author

The Wood equation allows consistent fitting of individual antibody-response profiles of Zika virus or SARS-CoV-2 infected patients.

Heliyon·2023
Same author

Already low drug dose antagonism of the renin-angiotensin aldosterone system decreases 1-year mortality and rehospitalization in old heart failure patients.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2022
Same author

Necrotizing myopathy associated with TET2-mutated myelodysplastic syndrome.

QJM : monthly journal of the Association of Physicians·2022
Same author

[A check-list in order to optimise the deployment of computerized medicine cabinets in a hospital: An essential support].

Annales pharmaceutiques francaises·2021

Area of Science:

  • Oncology
  • Public Health
  • Gynecology

Background:

  • Incidence and mortality rates of cervical cancer are decreasing in France and Europe.
  • Opportunistic cervical cancer screening is common, with 60% of women participating, higher in younger age groups.
  • National guidelines for cervical cancer screening (ages 25-65, every 3 years) were established in 1990.

Purpose of the Study:

  • To evaluate the effectiveness of organized cervical cancer screening pilot programs in France.
  • To assess participation rates, abnormal test rates, and cancer detection rates within these programs.
  • To inform strategies for improving screening coverage and quality control.

Main Methods:

  • Implementation of four population-based, organized cervical cancer screening pilot programs in Isère, Doubs, Bas-Rhin, and Martinique since 1990.

Related Experiment Videos

  • Monitoring of participation rates (20-80%), abnormal test rates (0.2-3%), and cancer detection rates (0.04-0.15%).
  • Evaluation of quality indicators for cervical smear taking and reading, guided by ANAES (national agency for health intervention evaluation).

    • Main Results:

    • Participation rates varied significantly (20-80%) based on age and geographic area.
    • Abnormal cervical smear rates ranged from 0.2% to 3%, and cancer detection rates from 0.04% to 0.15%.
    • A 1998 law made cervical cancer screening free under national recommendations, with plans for cytological quality control.

    Conclusions:

    • Cervical cancer screening programs show variable participation but contribute to early detection.
    • The implementation of free screening and enhanced quality control aims to improve cervical cancer prevention.
    • Further efforts are needed to reach under-screened populations and ensure equitable access to screening.